← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
WEYERHAEUSER CO: Revenue declined 3.1% to $6.905B from $7.124B. Net income declined 18.2% to $324M from $396M. Operating cash flow declined 44.2% to $562M from $1.008B. Operating margin expanded 97 bps to 10.59%. WEYERHAEUSER CO's annual comparison also shows the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 3.1% to $6.905B from $7.124BWatch
- Profitability — Net income declined 18.2% to $324M from $396MWatch
- Cash flow — Operating cash flow declined 44.2% to $562M from $1.008BWatch
- Margins — Operating margin expanded 97 bps to 10.59%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 4 purchases and 2 salesOK
Business
WOOD PRODUCTS We are one of the largest manufacturers and distributors of wood products in North America.
Where the revenue comes from
Fiscal 2025, as WEYERHAEUSER CO reports it. History and quarterly detail are in the app.
- Structurallumber$2.0B
- Deliveredlogs$1.3B
- Oriented Strand Board$762.0M
- Engineered Solid Section$649.0M
- Complementarybuildingproducts$565.0M
Latest filings
- 8-K · Company announcement2026-08-27
- 10-Q · Quarterly report2026-07-31
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-06-25
- 8-K · Company announcement2026-05-28
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about WEYERHAEUSER CO, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.